Cargando…

Heme oxygenase-1 is a predictive biomarker for therapeutic targeting of advanced clear cell renal cell carcinoma treated with sorafenib or sunitinib

BACKGROUND: We analyzed the expression of heme oxygenase-1 (HO-1) in patients undergoing radical nephrectomy for advanced clear cell renal cell carcinoma (CC-RCC) and evaluated the effects of the targeted therapies treated with sorafenib and sunitinib. METHODS: Expression of HO-1 in cancer tissue fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Wan-Xiang, Yan, Fei, Xue, Qin, Wu, Guo-Jun, Qin, Wei-Jun, Wang, Fu-Li, Qin, Jun, Tian, Chun-Juan, Yuan, Jian-Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539079/ https://www.ncbi.nlm.nih.gov/pubmed/26309414 http://dx.doi.org/10.2147/OTT.S86222

Ejemplares similares

Sorafenib and docosahexaenoic acid act in synergy to suppress cancer cell viability: a role of heme oxygenase 1
por: Jiao, Yang, et al.
Publicado: (2018)

Efficacy of sequential therapies with sorafenib-sunitinib versus sunitinib-sorafenib in metastatic renal cell carcinoma: A systematic review and meta-analysis
por: Wen, Tingyu, et al.
Publicado: (2017)

Successful treatment with sorafenib for sunitinib‐refractory metastatic papillary renal cell carcinoma: Potential impact of Raf overexpression on predicting the efficacy of sorafenib
por: Morinaga, Ryota, et al.
Publicado: (2018)

The roles of heme oxygenase-1 in renal disease
por: Zhai, Hongfu, et al.
Publicado: (2023)

Adverse reactions of sorafenib, sunitinib, and imatinib in treating digestive system tumors
por: Fu, Yali, et al.
Publicado: (2018)

Sequential Treatment Based on Sunitinib and Sorafenib in Patients with Metastatic Renal Cell Carcinoma
por: Schlemmer, Marcus, et al.
Publicado: (2019)

Octreotide attenuates liver fibrosis by inhibiting hepatic heme oxygenase-1 expression
por: GUO, SHI-BIN, et al.
Publicado: (2015)

Therapeutic Efficacy of Stem Cells Transplantation in Diabetes: Role of Heme Oxygenase
por: Raffaele, Marco, et al.
Publicado: (2016)

HIF pathway and c-Myc as biomarkers for response to sunitinib in metastatic clear-cell renal cell carcinoma
por: Maroto, P, et al.
Publicado: (2017)

Therapeutic Roles of Heme Oxygenase-1 in Metabolic Diseases: Curcumin and Resveratrol Analogues as Possible Inducers of Heme Oxygenase-1
por: Son, Yong, et al.
Publicado: (2013)

Severe clinical toxicities are correlated with survival in patients with advanced renal cell carcinoma treated with sunitinib and sorafenib
por: Di Fiore, F, et al.
Publicado: (2011)

Treatment with sorafenib and sunitinib in renal cell cancer: a Swedish register-based study
por: Ambring, Anneli, et al.
Publicado: (2012)

Effects and Side Effects of Using Sorafenib and Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma
por: Randrup Hansen, Caroline, et al.
Publicado: (2017)

Oxypurinol protects renal ischemia/reperfusion injury via heme oxygenase-1 induction
por: Kang, Hye Bin, et al.
Publicado: (2023)

How Heme Oxygenase-1 Prevents Heme-Induced Cell Death
por: Lanceta, Lilibeth, et al.
Publicado: (2015)

Dyskerin and telomerase RNA component are sex-differentially associated with outcomes and Sunitinib response in patients with clear cell renal cell carcinoma
por: Yuan, Huiyang, et al.
Publicado: (2023)

Therapeutic Potential of Heme Oxygenase-1 in Aneurysmal Diseases
por: Jiang, Wei-Cheng, et al.
Publicado: (2020)

Role of Heme Oxygenase in Gastrointestinal Epithelial Cells
por: Akagi, Reiko
Publicado: (2022)

Identification of MX2 as a Novel Prognostic Biomarker for Sunitinib Resistance in Clear Cell Renal Cell Carcinoma
por: Wei, Yuang, et al.
Publicado: (2021)

Sorafenib and sunitinib: A dermatologist's perspective
por: Pragasam, Vijendran, et al.
Publicado: (2014)

Overexpression of Heme Oxygenase-1 Prevents Renal Interstitial Inflammation and Fibrosis Induced by Unilateral Ureter Obstruction
por: Chen, Xiao, et al.
Publicado: (2016)

miRNA-381 regulates renal cancer stem cell properties and sunitinib resistance via targeting SOX4
por: Lu, Xiao-jun, et al.
Publicado: (2023)

Implication of heme oxygenase-1 in the sensitivity of nasopharyngeal carcinomas to radiotherapy
por: Shi, Lei, et al.
Publicado: (2008)

Predictive Immunohistochemical Markers Related to Drug Selection for Patients Treated with Sunitinib or Sorafenib for Metastatic Renal Cell Cancer
por: Ma, Xin, et al.
Publicado: (2016)

Comparative efficacy and safety of sunitinib vs sorafenib in renal cell carcinoma: A systematic review and meta-analysis
por: Liu, Xiu-Lan, et al.
Publicado: (2020)

Everolimus: the first approved product for patients with advanced renal cell cancer after sunitinib and/or sorafenib
por: Coppin, Chris
Publicado: (2010)

Mechanisms by which heme oxygenase rescue renal dysfunction in obesity
por: Ndisang, Joseph Fomusi, et al.
Publicado: (2014)

Heme Oxygenase-1 Deficiency
por: Renji, Soumya, et al.
Publicado: (2021)

Heme Oxygenase-1 (HO-1) Expression in Prostate Cancer Cells Modulates the Oxidative Response in Bone Cells
por: Ferrando, Mercedes, et al.
Publicado: (2013)

The chromosomal instability 25 gene signature is identified in clear cell renal cell carcinoma and serves as a predictor for survival and Sunitinib response
por: Wang, Chang, et al.
Publicado: (2023)

Heme Oxygenase-1: Its Therapeutic Roles in Inflammatory Diseases
por: Pae, Hyun-Ock, et al.
Publicado: (2009)

Therapeutic potential of statins and the induction of heme oxygenase-1 in preeclampsia()
por: Ramma, Wenda, et al.
Publicado: (2014)

Heme Oxygenase-1 as Therapeutic Target for Diabetic Foot Ulcers
por: Leal, Ermelindo Carreira, et al.
Publicado: (2022)

Heme Oxygenase Modulation Drives Ferroptosis in TNBC Cells
por: Consoli, Valeria, et al.
Publicado: (2022)

Comparison of efficacy and safety among axitinib, sunitinib, and sorafenib as neoadjuvant therapy for renal cell carcinoma: a retrospective study
por: Cai, Wen, et al.
Publicado: (2019)

Key sunitinib‐related biomarkers for renal cell carcinoma
por: Peng, Yun, et al.
Publicado: (2021)

Acute Acalculous Cholecystitis in Patients With Clear Cell Renal Cell Carcinoma Treated With Sunitinib: Report of Two Cases
por: Furubayashi, Nobuki, et al.
Publicado: (2014)

Predictive value of C-reactive protein in patients treated with sunitinib for metastatic clear cell renal cell carcinoma
por: Pilskog, Martin, et al.
Publicado: (2017)

Metalloporphyrins as Tools for Deciphering the Role of Heme Oxygenase in Renal Immune Injury
por: Lianos, Elias A., et al.
Publicado: (2023)

In vivo and in vitro effects of heme oxygenase-1 silencing on the survival of acute myelocytic leukemia-M2 cells
por: WEI, SIXI, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_umroeucb468abaqmojjfnct7if